Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an update.
Recordati has completed a share buyback programme launched in December 2025 to supply stock option and performance share plans for its management and future share-based incentive schemes. Between 17 December 2025 and 24 March 2026, the company repurchased 1,000,000 shares, equal to 0.478% of its share capital, for a total of €47.0 million and now holds 5,703,240 treasury shares, or 2.727% of its capital, consolidating its flexibility in managing long-term executive remuneration and alignment with shareholders.
The final tranche of the programme, executed between 16 and 24 March 2026 via UBS Europe SE, involved buying 168,840 shares at a weighted average price of €44.70 on the Italian stock exchange. The completion of the buyback strengthens Recordati’s ability to support existing and future equity-based incentives, which are a key tool in retaining and motivating management in a competitive global pharmaceuticals market, without immediately altering control structure but modestly increasing treasury stock.
The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on Borsa Italiana that develops, manufactures and markets active pharmaceutical ingredients and finished drugs for both general and specialist medicine, as well as treatments for rare diseases. Founded in the 1920s in Northern Italy, it now operates in about 150 countries across EMEA, the Americas and APAC with more than 4,580 employees, following a fully integrated model from clinical development to commercialization.
Average Trading Volume: 339,738
Technical Sentiment Signal: Hold
Current Market Cap: €9.4B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.